However, over the past decade, the emergence of molecular markers has redefined the WHO classification.8–14 In adult gliomas, neomorphic mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2), most commonly R132H and R172K, respectively, are the most important molecular classifiers. This evidence concerns the gene IDH2 and glioma.